United States · Markets & Finance · Bloomberg

Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials

Published by Bloomberg · United States 5 h ago

Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.

Read the full article on Bloomberg Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

Also worth reading

Anthropic can’t reliably control its AI agents. It’s cutting off its internal evals from the live internet instead

Business Insider

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Big Controversy Upends a Contest About Microscopic Videos

Why Record Crude Output Can’t Solve America’s Diesel Crisis